FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoseph Caraco

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Administration, Oral

Phenomena

Physiology

Disorders

Obesity

Co-author Network

Publications

TOP 3
Mordechai Muszkat; Esther Orlanski-Meyer; Einav Porat; Simcha Blotnick; Elyad M Davidson; Assaf Hoofien; Hani Makhoul; Yoseph Caraco
The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β(1) adrenergic receptor antagonist esmolol in healthy individuals.
Liat Mlynarsky; Mordechai Muszkat; Idit Bejarano-Achache; Yoseph Caraco
Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriers.
Idit Bejarano-Achache; Meir Bialer; Liran Levy; Liat Mlynarsky; Mordechai Muszkat; Yoseph Caraco
Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoseph Caraco (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mordechai Muszkat; Esther Orlanski-Meyer; Einav Porat; Simcha Blotnick; Elyad M Davidson; Assaf Hoofien; Hani Makhoul; Yoseph Caraco
The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β(1) adrenergic receptor antagonist esmolol in healthy individuals.
Pharmacogenetics and genomics 2013;23(1):25-8.
2012: Liat Mlynarsky; Mordechai Muszkat; Idit Bejarano-Achache; Yoseph Caraco
Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriers.
European journal of clinical pharmacology 2012;68(5):617-27.
2012: Idit Bejarano-Achache; Meir Bialer; Liran Levy; Liat Mlynarsky; Mordechai Muszkat; Yoseph Caraco
Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study.
Clinical therapeutics 2012;34(4):811-23.
2011: Gilad Rosenberg; Linda S Marshall; Yoseph Caraco
The neuroprotective agent DP-b99 does not interact with s-warfarin in vivo despite significant CYP2C9 inhibition in vitro.
Basic & clinical pharmacology & toxicology 2011;108(4):289-92.
2010: Mordechai Muszkat; Omer Bialer; Simcha Blotnick; Liat Adar; Hong-Guang Xie; Mike Ufer; Ingolf Cascorbi; Yoseph Caraco
Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adults.
Clinical therapeutics 2010;32(2):347-56.
2009: Yehuda Ginosar; Elyad M Davidson; Y Meroz; S Blotnick; M Shacham; Yoseph Caraco
Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: a pharmacokinetic-pharmacodynamic study.
British journal of anaesthesia 2009;103(3):420-7.
2008: Yoseph Caraco; S Blotnick; Mordechai Muszkat
CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.
Clinical pharmacology and therapeutics 2008;83(3):460-70.
2007: Jawad M Khalaila; Amir Elami; Yoseph Caraco
Interaction between beta2 adrenergic receptor polymorphisms determines the extent of isoproterenol-induced vasodilatation ex vivo.
Pharmacogenetics and genomics 2007;17(10):803-11.
2007: Mordechai Muszkat; Simcha Blotnik; Amir Elami; Irena Krasilnikov; Yoseph Caraco
Warfarin metabolism and anticoagulant effect: a prospective, observational study of the impact of CYP2C9 genetic polymorphism in the presence of drug-disease and drug-drug interactions.
Clinical therapeutics 2007;29(3):427-37.
2006: Abu Fanne Rami; Daniel Barkan; Dror Mevorach; eran leitersdorf; Yoseph Caraco
Clozapine-induced systemic lupus erythematosus.
The Annals of pharmacotherapy 2006;40(5):983-5.
2004: Yoseph Caraco
Genes and the response to drugs.
The New England journal of medicine 2004;351(27):2867-9.
2003: Harumi Takahashi; Grant R Wilkinson; Yoseph Caraco; Mordechai Muszkat; Richard B Kim; Toshitaka Kashima; Sosuke Kimura; Hirotoshi Echizen
Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients.
Clinical pharmacology and therapeutics 2003;73(3):253-63.
2002: Oren Shibolet; Olga Schatz; Michal Krieger; Alexander Maly; Yoseph Caraco
Schnitzler syndrome: chronic urticaria, fever and immunoglobulin M monoclonal gammopathy.
The Israel Medical Association journal : IMAJ 2002;4(6):466-7.
2002: Aharon Bloch; Eldad Ben-Chetrit; Mordechai Muszkat; Yoseph Caraco
Major bleeding caused by warfarin in a genetically susceptible patient.
Pharmacotherapy 2002;22(1):97-101.
2001: Yoseph Caraco; Mordechai Muszkat; A J Wood
Phenytoin metabolic ratio: a putative marker of CYP2C9 activity in vivo.
Pharmacogenetics 2001;11(7):587-96.
2001: Micha Levy; Rifaat Safadi; Ester Zylber-Katz; L Granit; Yoseph Caraco
Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators.
European journal of clinical pharmacology 2001;57(6-7):461-5.
2000: B Hirshberg; Alexander Gural; Yoseph Caraco
Zuclopenthixol-associated neutropenia and thrombocytopenia.
The Annals of pharmacotherapy 2000;34(6):740-2.
2000: B Hirshberg; Michael Y Shapira; I Grinblat; L Shustin; Yoseph Caraco
Lack of mediastinal shift as a clue to delayed postpneumonectomy empyema.
Southern medical journal 2000;93(1):80-2.
1999: Yoseph Caraco; Ester Zylber-Katz; M Fridlander; Dan Admon; Micha Levy
The effect of short-term dipyrone administration on cyclosporin pharmacokinetics.
European journal of clinical pharmacology 1999;55(6):475-8.
1999: R Adler; Rifaat Safadi; Yoseph Caraco; M Rowe; A Etzioni; Yaffa Ashur; Daniel Shouval
Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation.
Hepatology (Baltimore, Md.) 1999;29(4):1299-305.
1999: Sigal Sviri; Shoshi Shpizen; eran leitersdorf; Micha Levy; Yoseph Caraco
Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population.
Clinical pharmacology and therapeutics 1999;65(3):275-82.
1998: Mordechai Muszkat; Michael Y Shapira; Sigal Sviri; David M Linton; Yoseph Caraco
Ticlopidine-induced thrombotic thrombocytopenic purpura.
Pharmacotherapy 1998;18(6):1352-5.
1998: Yoseph Caraco
Genetic determinants of drug responsiveness and drug interactions.
Therapeutic drug monitoring 1998;20(5):517-24.
1998: O Cohen; Ester Zylber-Katz; Yoseph Caraco; L Granit; Micha Levy
Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone.
European journal of clinical pharmacology 1998;54(7):549-53.
1998: Micha Levy; K Brune; Ester Zylber-Katz; O Cohen; Yoseph Caraco; G Geisslinger
Cerebrospinal fluid prostaglandins after systemic dipyrone intake.
Clinical pharmacology and therapeutics 1998;64(1):117-22.
1998: M Levy; Yoseph Caraco; G Geisslinger
Drug acetylation in liver disease.
Clinical pharmacokinetics 1998;34(3):219-26.
1997: O Caspi; Ester Zylber-Katz; O Gotsman; Dana G Wolf; Yoseph Caraco
Digoxin intoxication in a patient with end-stage renal disease: efficacy of digoxin-specific Fab antibody fragments and peritoneal dialysis.
Therapeutic drug monitoring 1997;19(5):510-5.
1997: Micha Levy; I Leibowich; Ester Zylber-Katz; Y Ilan; L Granit; Sigal Sviri; Yoseph Caraco
Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis B virus.
Clinical pharmacology and therapeutics 1997;62(1):6-14.
1995: Rifaat Safadi; I Levy; Y Amitai; Yoseph Caraco
Beneficial effect of digoxin-specific Fab antibody fragments in oleander intoxication.
Archives of internal medicine 1995;155(19):2121-5.
1995: Yoseph Caraco; Ester Zylber-Katz; Elliot M Berry; Micha Levy
Carbamazepine pharmacokinetics in obese and lean subjects.
The Annals of pharmacotherapy 1995;29(9):843-7.
1995: Ester Zylber-Katz; Yoseph Caraco; L Granit; M Levy
Dipyrone metabolism in liver disease.
Clinical pharmacology and therapeutics 1995;58(2):198-209.
1995: Yoseph Caraco; Ester Zylber-Katz; Elliot M Berry; Micha Levy
Caffeine pharmacokinetics in obesity and following significant weight reduction.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1995;19(4):234-9.
1995: Yoseph Caraco; Ester Zylber-Katz; Elliot M Berry; Micha Levy
Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism.
European journal of clinical pharmacology 1995;47(6):525-30.
1994: Ester Zylber-Katz; Chaim Putterman; Yoseph Caraco
Multiple drug overdose in a kidney transplant patient.
Therapeutic drug monitoring 1994;16(3):327-31.
1993: Yoseph Caraco; Ester Zylber-Katz; L Granit; Micha Levy
Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics.
Arzneimittel-Forschung 1993;43(11):1204-8.
1992: Chaim Putterman; B Tadmor; L Simer; Yoseph Caraco
Recurrent venous thrombosis as the presenting sign of two primary lung carcinomas--15 years apart.
Respiratory medicine 1992;86(6):521-3.
1992: Yoseph Caraco; R Arnon; D Raveh
Quinidine-induced uveitis.
Israel journal of medical sciences 1992;28(10):741-3.
1992: Yoseph Caraco; A Rubinow
Enhanced anticoagulant effect of coumarin derivatives induced by doxycycline coadministration.
The Annals of pharmacotherapy 1992;26(9):1084-6.
1992: Yoseph Caraco; Ester Zylber-Katz; Elliot M Berry; Micha Levy
Significant weight reduction in obese subjects enhances carbamazepine elimination.
Clinical pharmacology and therapeutics 1992;51(5):501-6.
1992: Yoseph Caraco; Chaim Putterman; R Rahamimov; Eldad Ben-Chetrit
Acute colchicine intoxication--possible role of erythromycin administration.
The Journal of rheumatology 1992;19(3):494-6.
1991: Chaim Putterman; Eldad Ben-Chetrit; Yoseph Caraco; Micha Levy
Colchicine intoxication: clinical pharmacology, risk factors, features, and management.
Seminars in arthritis and rheumatism 1991;21(3):143-55.
1991: Chaim Putterman; Y Almog; Yoseph Caraco; David J Gross; Eldad Ben-Chetrit
Inappropriate secretion of antidiuretic hormone in Sheehan's syndrome: a rare cause of postpartum hyponatremia.
American journal of obstetrics and gynecology 1991;165(5 Pt 1):1330-3.
1991: Chaim Putterman; Yoseph Caraco; M Shalit
Acute nonrheumatic perimyocarditis complicating streptococcal tonsillitis.
Cardiology 1991;78(2):156-60.
1991: Elliot M Berry; Yoseph Caraco; D Roth
T3 levels in anorexia nervosa.
Journal of the American Academy of Child and Adolescent Psychiatry 1991;30(1):156-7.
1990: Yoseph Caraco; Ester Zylber-Katz; L Granit; M Levy
Does restriction of caffeine intake affect mixed function oxidase activity and caffeine metabolism?
Biopharmaceutics & drug disposition 1990;11(7):639-43.
1990: S Gillis; B Friedman; Yoseph Caraco; A Blankstein; A Yellin; G Friedman
Septic arthritis of the sternoclavicular joint in healthy adults.
Journal of internal medicine 1990;228(3):275-8.
1989: Yoseph Caraco; Tova Chajek-Shaul
The incidence and clinical significance of amiodarone and acenocoumarol interaction.
Thrombosis and haemostasis 1989;62(3):906-8.
1988: Yoseph Caraco; D Raveh; M Flugelman; Itamar Raz
Enhanced anticoagulant effect of acenocoumarol induced by amiodarone coadministration.
Israel journal of medical sciences 1988;24(11):688-9.
1987: Yoseph Caraco; D Raveh; I Raz
Shigella sonnei myocarditis.
Clinical cardiology 1987;10(7):423-4.